Goldman Sachs tips Cochlear share price to rise 13%

One leading broker is bullish on Cochlear's shares…

| More on:
A man sees some good news on his phone and gives a little cheer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Cochlear Limited (ASX: COH) share price could be heading higher from current levels.

That's the view of analysts at Goldman Sachs, which have just reiterated their buy rating on the hearing solutions company's shares.

This follows the release of a strong full year result for FY 2022 last week.

What is Goldman saying about the Cochlear share price?

According to note out of the investment bank, Goldman has reiterated its buy rating with an improved price target of $247.00.

Based on the current Cochlear share price of $218.86, this implies potential upside of 13% for investors over the next 12 months.

Goldman was impressed with the company's performance, noting that "in a highly challenging year Cochlear delivered +17% NPAT growth to reach the upper-half of the guided range."

The good news is that the broker is expecting more of the same in FY 2023. It said:

In our view, the backdrop for this year appears relatively more favourable, and we see clear scope for COH to deliver at the upper-end of another solid guidance (+8-13% to $290-305m, with further accretion possible from the Oticon Medical transaction, which is yet to close).

What about the medium term?

The good news for the Cochlear share price is that Goldman Sachs doesn't expect the company's growth to stop in FY 2023.

Its analysts believe the company is well-placed to continue this solid form through until at least FY 2025. It explained:

Overall, our NPAT forecast of $301m is at the upper-end of the guided range $290-305m, and we forecast a +10% CAGR from FY22-25E.

And while the broker acknowledges that Cochlear's shares are not cheap at current levels, it still believes they are good value compared to historic multiples and due to its positive and uncomplicated outlook. The broker said:

Whilst valuation of 28x EV/EBITDA appears high in absolute terms, it is still only in-line with its 5-year average and modestly above its 10-yr. Looking across the other 'recovery' plays in our coverage, there is less complexity to COH's near/mid-term earnings profile, and we believe it will ultimately experience lower and/or shorter-lived margin pressure through the pandemic period than peers.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Broker Notes

3 of the best ASX stocks to buy now with $2,500

These shares are highly rated by the team at Bell Potter.

Read more »

A man in suit and tie is smug about his suitcase bursting with cash.
Broker Notes

2 big-name ASX 200 shares brokers rate as top buys

Let's see which shares could be in the buy zone right now.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Broker Notes

3 Australian shares to buy and hold for the next 5 years

Let's see why analysts think these stocks could be worth holding tightly to for the remainder of the 2020s.

Read more »

A person sitting at a desk smiling and looking at a computer.
Broker Notes

4 ASX tech shares impressing analysts today

Four technology companies featured prominently in Wilson Asset Management's recent investment updates.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Bell Potter names the best ASX shares to buy

Let's see which shares the broker is bullish on this month.

Read more »

Business man at desk looking out window with his arms behind his head at a view of the city and stock trends overlay.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

How much upside does Macquarie see for Collins Foods shares?

The company is scheduled to report on 24 June.

Read more »